PWA
CUE icon

Physician Wealth Advisors’s Cue Biopharma CUE Stock Holding History

Physician Wealth Advisors’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04K Sell
33
-1
-3% -$23 ﹤0.01% 1820
2026
Q1 		$232 Hold
34
– – ﹤0.01% 2021
2025
Q4 		$308 Hold
34
– – ﹤0.01% 1977
2025
Q3 		$724 Hold
34
– – ﹤0.01% 1720
2025
Q2 		$687 Hold
34
– – ﹤0.01% 1613
2025
Q1 		$917 Hold
34
– – ﹤0.01% 1137
2024
Q4 		$1.1K Buy
+34
New +$1.28K ﹤0.01% 925

Other funds holding CUE

RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Physician Wealth Advisors's CUE Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Cue Biopharma (CUE) stake by 2.9% in Q2 2026, selling an estimated $23 and leaving 33 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

Physician Wealth Advisors first reported a position in CUE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.1K in Q4 2024. 8 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Physician Wealth Advisors held 33 shares of Cue Biopharma worth $1.04K as of Q2 2026.
  • Physician Wealth Advisors sold 1 Cue Biopharma share in Q2 2026, an estimated $23.
  • Cue Biopharma made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1820 holding.
  • Physician Wealth Advisors first reported a position in Cue Biopharma in Q4 2024 and has held it in 7 quarters since.
  • Physician Wealth Advisors's Cue Biopharma position peaked at $1.1K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.